PositiveID Corporation™

- •
- •
- •
- •
- •
- •
- •
- •
- •

Innovative Health Solutions

PositiveID's innovative and advanced healthcare and medical solutions, developed from its expanding intellectual property portfolio, are designed to address unmet needs in the market. From non-invasive blood glucose monitoring through the creation of novel sensing devices, to rapid and precise biological detection at the point-of-care, PositiveID provides tools and technologies for a better quality of life.

Click here to view our products

PositiveID Corporation™ (OTCBB: PSID)

PositiveID develops unique medical devices and biological detection systems focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MicroFluidic Systems or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays.

M-BAND

MFS specializes in airborne pathogen detection, rapid clinical diagnostics and sample preparation applications. more

iglucose

iglucose is a next-generation mobile health system for simplified diabetes management. more

Easy Check

Easy Check is a non-invasive breath glucose detection device currently under development in Israel. more

GlucoChip

Taking the capabilities of RFID implantable microchips beyond identification, PositiveID is developing this glucose-sensing microchip based on a patent it received in 2006. more

Positive ID